Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cells and SVF for Temporomandibular Joint Disease
NCT05305833Phase 2Unknown
- Sponsor
- Erciyes University
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells, autologous adipose stromal vascular fraction in temporomandibular joint disorder (TMD), sponsored by Erciyes University. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cellsautologous adipose stromal vascular fraction
03
Conditions
temporomandibular joint disorder (TMD)
Beyond the preview
Go deeper on NCT05305833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05305833.